Covid-19 vaccine update: Bharat Biotech, Ocugen sign pact for supply of Covaxin to US market

Under the terms of the agreement, Pennsylvania-based Ocugen will have rights to the vaccine candidate in the US and will be responsible for clinical development, regulatory approval (including Emergency Use Authorisation) and commercialisation for the US market.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...